We are live on ! Find out more
KCM

Kornitzer Capital Management Portfolio holdings

AUM $4.79B
1-Year Est. Return 30.56%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+30.56%
3 Year Est. Return
+78.14%
5 Year Est. Return
+100.44%
10 Year Est. Return
+507.87%
AUM
$4.94B
AUM Growth
+$275M
Cap. Flow
-$134M
Cap. Flow %
-2.72%
Top 10 Hldgs %
16.92%
Holding
527
New
22
Increased
110
Reduced
192
Closed
28

Top Buys

Rank Stock Value
1
FIVN icon
FIVE9
FIVN
+$9.95M
2
OABI icon
OmniAb
OABI
+$9.24M
3
CLFD icon
Clearfield
CLFD
+$7.38M
4
MPWR icon
Monolithic Power Systems
MPWR
+$7.32M
5
SITM icon
SiTime
SITM
+$7.29M

Sector Composition

Rank Sector Weight
1 Technology 20.04%
2 Healthcare 18.33%
3 Energy 13.38%
4 Consumer Staples 11.65%
5 Industrials 11.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNN icon
276
Smith & Nephew
SNN
$12.6B
$3.42M 0.07%
127,000
PGNY icon
277
Progyny
PGNY
$2.04B
$3.4M 0.07%
109,024
MDLZ icon
278
Mondelez International
MDLZ
$78.9B
$3.34M 0.07%
50,126
-240
-0.5% -$15.2K
ABBV icon
279
AbbVie
ABBV
$442B
$3.28M 0.07%
20,322
-122
-0.6% -$18.7K
MKTX icon
280
MarketAxess Holdings
MKTX
$5.72B
$3.27M 0.07%
11,731
+260
+2% +$66.9K
KDP icon
281
Keurig Dr Pepper
KDP
$39.7B
$3.27M 0.07%
91,715
-2,675
-3% -$100K
PBI icon
282
Pitney Bowes
PBI
$2.27B
$3.2M 0.06%
842,060
-11,515
-1% -$38.8K
EFX icon
283
Equifax
EFX
$21.4B
$3.14M 0.06%
16,133
NFLX icon
284
Netflix
NFLX
$311B
$3.11M 0.06%
105,570
+2,190
+2% +$61.4K
CVS icon
285
CVS Health
CVS
$120B
$3.08M 0.06%
33,045
+7
+0% +$675
NVDA icon
286
NVIDIA
NVDA
$5.27T
$3.05M 0.06%
208,580
+16,430
+9% +$241K
JAZZ icon
287
Jazz Pharmaceuticals
JAZZ
$16.1B
$3.03M 0.06%
19,025
CRM icon
288
Salesforce
CRM
$162B
$2.97M 0.06%
22,391
-1,121
-5% -$164K
F icon
289
Ford
F
$55.7B
$2.96M 0.06%
254,600
+2,075
+0.8% +$26.7K
NKE icon
290
Nike
NKE
$61.3B
$2.9M 0.06%
24,780
+4
+0% +$403
HZNP
291
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$2.86M 0.06%
25,165
-227,621
-90% -$18.9M
NOW icon
292
ServiceNow
NOW
$132B
$2.85M 0.06%
36,655
+7,510
+26% +$587K
VRNS icon
293
Varonis Systems
VRNS
$4.84B
$2.77M 0.06%
115,700
-721,743
-86% -$16.5M
ADBE icon
294
Adobe
ADBE
$105B
$2.76M 0.06%
8,199
-2,265
-22% -$724K
HCA icon
295
HCA Healthcare
HCA
$89.1B
$2.75M 0.06%
11,475
-375
-3% -$84K
CPB icon
296
Campbell Soup
CPB
$6.78B
$2.72M 0.06%
48,004
-400
-0.8% -$21K
ON icon
297
ON Semiconductor
ON
$31.6B
$2.7M 0.05%
43,310
HAS icon
298
Hasbro
HAS
$13.7B
$2.67M 0.05%
43,797
-1,288
-3% -$80.4K
LMT icon
299
Lockheed Martin
LMT
$138B
$2.67M 0.05%
5,489
+490
+10% +$228K
LULU icon
300
lululemon athletica
LULU
$14.3B
$2.62M 0.05%
8,176
+1,550
+23% +$510K

Similar funds

Kornitzer Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Kornitzer Capital Management held 527 positions worth $4.94B, up 5.9% from $4.66B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Kornitzer Capital Management's Q4 2022 filing shows 22 new, 110 increased, 192 reduced and 28 closed positions. Its largest new stake was FIVE9: 158,520 shares worth $10.8M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $18.9M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Energy.

  • Kornitzer Capital Management's largest Q4 2022 buy was FIVE9: 158,520 shares worth $10.8M.
  • Kornitzer Capital Management added most to Bio-Rad Laboratories Class A in Q4 2022, an estimated $6.56M increase.
  • Kornitzer Capital Management's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $18.9M.
  • Kornitzer Capital Management fully exited First Advantage in Q4 2022, selling an estimated $6.24M.
  • Kornitzer Capital Management's ten largest holdings make up 17% of its $4.94B portfolio in Q4 2022.
  • Kornitzer Capital Management opened 22 new positions and closed 28 in Q4 2022.
  • Kornitzer Capital Management's portfolio value rose 5.9% quarter-over-quarter to $4.94B.

Based on Kornitzer Capital Management's 13F filing for Q4 2022, filed 2 Feb 2023.